Rx PHARMASIST.CA
The Pharmasist newsletter

Stay current in
Canadian pharmacy.

Pharmacy news, practice updates and fresh perspectives—delivered to your inbox.

Keep your practice informed

  • Canadian pharmacy news

    Follow the developments shaping the profession.

  • Prescriber updates

    Stay informed about newly licensed Ontario physicians.

  • What's new on Pharmasist

    Explore new resources, tools and learning opportunities.

Free newsletter

A useful addition to your inbox.

We'll send a confirmation link first. Privacy policy

All news Pharmasist News & insight

Four PegLyte powder lots recalled nationwide over possible foreign matter

Health Canada’s notice lists lots 260303 through 260306, DIN 00777838, in a retailer-level Type III recall by Pendopharm.

1 min read1 source
Share LinkedIn X Facebook Email
Illustrative photo accompanying this news article
Illustrative hospital pharmacy; not a recalled PegLyte product or incident site. Photo: User:Mattes / Wikimedia Commons, Public domain. Image source
In this article & details

Article details

Published
Nov 19, 2026
Reading time
1 min read
Categories
Medication Safety, Recalls
Jurisdiction
National
Sources cited
1
All news

Pendopharm is recalling four lots of PegLyte powder for solution across Canada because they may contain foreign matter, according to Health Canada’s November 17 notice.

The affected lots are 260303, 260304, 260305 and 260306. All are listed under DIN 00777838. The recalling firm is Pendopharm Division of Pharmascience Inc., based in Montréal.

Notice identifies the formulation and recall level

The product contains macrogol 238.18 g, potassium chloride 3.05 g, sodium bicarbonate 6.76 g, sodium chloride 5.85 g and sodium sulfate 22.96 g. The action is a Type III recall at the retailer level, identification number RA-82964.

The notice does not describe the foreign matter, identify its origin or quantify affected packages. Its product table specifies the four lots rather than every PegLyte package.

Health Canada asks people to verify whether their product is affected and consult their health-care provider before discontinuing it or about health concerns. Questions about the recall can be directed to the company. The department also requests reports of side effects and other health-product safety complaints.

References

  1. PegLyte Powder: Affected lots may contain foreign matter — Health Canada, November 17, 2026; recall RA-82964

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.